Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Senderowicz Adrian, Director. Director active across 1 company, notably Puma Biotechnology, INC.. Aggregated, 9 reports have been recorded. Split: 0 buy · 5 sells. Total volume traded: €992k. Activity tracked since 11 June 2021. The latest transaction was disclosed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
9 of 9 declarations
Adrian Senderowicz is a Board Member at Puma Biotechnology, Inc. He plays a vital role in the governance of the company, bringing his expertise in biopharmaceuticals and drug development. His involvement on the board contributes to Puma Biotechnology's strategic direction.